Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal first quarter revenues rose 5 percent year over year, largely due to a 9 percent increase in revenues from its life sciences business.

For the three months ended Dec. 31, the company posted revenues of $3.08 billion, compared to $2.92 billion in the year-ago quarter, beating Wall Street analysts' average estimate of $3.05 billion. On a currency-neutral basis, revenues grew 4 percent, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.